LeadIQ logo
Learn more at LeadIQ.com

Insights

Merger & Partnership Opportunities Dynacure recently merged with Flamingo and partnered with Artcapman, indicating potential opportunities for collaborations or partnerships with companies in the biotechnology and rare disease sectors.

Expanding Research Portfolio With the development of DYN101 for Myotubular and Centronuclear Myopathies and the DYN201 program for Hereditary Spastic Paraplegias, Dynacure is expanding its research portfolio, presenting opportunities for strategic alliances or licensing agreements.

Financial Growth Potential Having raised $54M in funding and engaged in commercialization agreements, Dynacure shows financial stability and growth potential, offering opportunities for investment or sales partnerships.

Public Offering and Market Presence Dynacure's IPO and strategic partnerships, such as with Nippon Shinyaku, enhance its market presence, creating opportunities for investor relations and expanding market reach.

Innovative Therapy Development Through the development of novel therapies targeting rare diseases, Dynacure demonstrates innovation in the biotechnology sector, offering potential avenues for licensing agreements or product distribution partnerships.

Similar companies to Dynacure

Dynacure Tech Stack

Dynacure uses 8 technology products and services including WordPress, CookieYes, Twitter Emoji (Twemoji), and more. Explore Dynacure's tech stack below.

  • WordPress
    Content Management System
  • CookieYes
    Cookie Compliance
  • Twitter Emoji (Twemoji)
    Font Scripts
  • jQuery
    Javascript Libraries
  • Yoast SEO
    Search Engines
  • MonsterInsights
    Web Platform Extensions
  • Nginx
    Web Servers
  • Slider Revolution
    Widgets

Media & News

Dynacure's Email Address Formats

Dynacure uses at least 1 format(s):
Dynacure Email FormatsExamplePercentage
First.Last@dynacure.comJohn.Doe@dynacure.com
50%
First.Last@dynacure.comJohn.Doe@dynacure.com
50%

Frequently Asked Questions

Where is Dynacure's headquarters located?

Minus sign iconPlus sign icon
Dynacure's main headquarters is located at Illkirch-Graffenstaden, Grand Est 67218 /67400 FR. The company has employees across 1 continents, including Europe.

What is Dynacure's stock symbol?

Minus sign iconPlus sign icon
Dynacure is a publicly traded company; the company's stock symbol is DYCU.

What is Dynacure's official website and social media links?

Minus sign iconPlus sign icon
Dynacure's official website is dynacure.com and has social profiles on LinkedIn.

What is Dynacure's SIC code NAICS code?

Minus sign iconPlus sign icon
Dynacure's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Dynacure have currently?

Minus sign iconPlus sign icon
As of October 2022, Dynacure has approximately 27 employees across 1 continents, including Europe. Key team members include Owner: W. V.: S. C.. Explore Dynacure's employee directory with LeadIQ.

What industry does Dynacure belong to?

Minus sign iconPlus sign icon
Dynacure operates in the Biotechnology Research industry.

What technology does Dynacure use?

Minus sign iconPlus sign icon
Dynacure's tech stack includes WordPressCookieYesTwitter Emoji (Twemoji)jQueryYoast SEOMonsterInsightsNginxSlider Revolution.

What is Dynacure's email format?

Minus sign iconPlus sign icon
Dynacure's email format typically follows the pattern of . Find more Dynacure email formats with LeadIQ.

How much funding has Dynacure raised to date?

Minus sign iconPlus sign icon
As of October 2022, Dynacure has raised $54M in funding. The last funding round occurred on Apr 02, 2020 for $54M.
Dynacure

Dynacure

Biotechnology ResearchGrand Est, France11-50 Employees

Dynacure is a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Dynacure is developing DYN101, an investigational antisense product candidate designed to reduce the expression of dynamin 2 protein for the treatment of Myotubular and Centronuclear Myopathies, in strategic collaboration with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders, including its DYN201 program for the treatment of Hereditary Spastic Paraplegias. 
Dynacure is headquartered in Strasbourg, France with a corporate office in Philadelphia, PA, USA. 

Section iconCompany Overview

Headquarters
Illkirch-Graffenstaden, Grand Est 67218 /67400 FR
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
DYCU
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $54M

    Dynacure has raised a total of $54M of funding over 3 rounds. Their latest funding round was raised on Apr 02, 2020 in the amount of $54M.

Section iconFunding & Financials

  • $54M

    Dynacure has raised a total of $54M of funding over 3 rounds. Their latest funding round was raised on Apr 02, 2020 in the amount of $54M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.